Ranking Alexa Global: # 7,533,589
Server:Apache/2.4.18 (Win64...
X-Powered-By:PHP/5.6.17
The main IP address: 159.220.59.6,Your server United States,Stamford ISP:Thomson Reuters U.S. LLC TLD:org CountryCode:US
The description :slide of the month archive >...
This report updates in 27-Nov-2018
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host cirsci.org. Currently, hosted in United States and its service provider is Thomson Reuters U.S. LLC .
Latitude: | 41.054096221924 |
Longitude: | -73.542182922363 |
Country: | United States (US) |
City: | Stamford |
Region: | Connecticut |
ISP: | Thomson Reuters U.S. LLC |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.18 (Win64) PHP/5.6.17 containing the details of what the browser wants and will accept back from the web server.
X-Powered-By: | PHP/5.6.17 |
Transfer-Encoding: | chunked |
Set-Cookie: | PHPSESSID=gaq7naujomt4a0emovla174k56; path=/ |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Keep-Alive: | timeout=5, max=100 |
Server: | Apache/2.4.18 (Win64) PHP/5.6.17 |
Connection: | Keep-Alive |
Link: | |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Date: | Mon, 26 Nov 2018 18:04:51 GMT |
Content-Type: | text/html; charset=UTF-8 |
X-Pingback: | http://www.cirsci.org/xmlrpc.php |
soa: | ha1.markmonitor.zone. hostmaster.markmonitor.com. 2018091101 3600 600 604800 172800 |
txt: | "v=spf1 include:spf.protection.outlook.com include:spf-0030e801.pphosted.com -all" "MS=ms81586478" |
ns: | ha2.markmonitor.zone. ha1.markmonitor.zone. ha3.markmonitor.zone. ha4.markmonitor.zone. |
ipv4: | IP:159.220.59.6 ASN:16050 OWNER:REUTERS-DOCKLANDS-RES-AS Reuters Docklands resiliancy, GB Country:US |
mx: | MX preference = 10, mail exchanger = mxa-0030e801.gslb.pphosted.com. MX preference = 10, mail exchanger = mxb-0030e801.gslb.pphosted.com. |
home member login contact us the centre for innovation in regulatory science (cirs) is a neutral, independent organisation conducting novel research, convening international forums for healthcare stakeholders and providing science-based insights to advance global regulatory and hta policies and enhance patient access to medicines. cirs: the centre for innovation in regulatory science about us mission history of cirs advisory committees member companies participating regulatory authorities participating hta and coverage bodies global development programme research programmes isabre flexible regulatory pathways annual mature regulatory agency metrics assessment programme emerging markets industry metrics assessing hurdles and enablers of regulatory performance quality decision making quality scorecards good review practices apec initiative publications and presentations regulatory metrics snapshots hta and market access programme research hta agency performance metrics hta industry performance metrics regulatory and reimbursement atlas canadian hta/payer agency metrics assessment project stakeholder survey: early scientific advice assessing the interactions between regulatory approval and hta recommendations factors influencing hta recommendations publications and presentations hta metrics snapshots coming soon opera workshops past workshops upcoming workshops publications decision making tools cirs-brat framework umbra initiative slide of the month breakdown of rollout time from first world-wide regulatory submission to jurisdictional hta recommendation (days) across 7 jurisdictions for 24 common new active substances more slide of the month archive > cirs news cirs senior research analyst magda bujar wins margaret k b day prize contact us our people search our site member login members have access to: • past workshop slides • atlas and much more. login to our cirs member’s section cirs 2018 agenda download the cirs 2018 agenda where to meet us the latin america forum at the regulatory affairs professionals society (raps) regulatory convergence; vancouver convention centre, vancouver, bc; wednesday, 3 october 2019, 10:30 am-12:00 pm (overall conference, 1-4 october, 2019) dr lawrence liberti, speaker: “state of the art facilitated regulatory pathways: global and latin america overview” malaysia national regulatory conference (nrc) 2018; 2-4 october 2018; selangor, malaysia international society for pharmacoeconomics and outcomes research (ispor) europe 2018; 10-14 november 2018; barcelona spain read our most recent publications r&d; briefing 68: regulatory and hta decision making and access to medicines: the consequence of sequence r&d; briefing 69: review of hta outcomes and timelines in australia, canada and europe 2014-2017 liberti l. the practical application of regulatory science: impact on regulatory policy and practice. reg rapporteur . 2018; 15:3-5-9. mashaki ceyhan e, gürsöz h, alkan a, coşkun h, koyuncu o, walker s. the turkish medicines and medical devices agency: comparison of its registration process with australia, canada, saudi arabia, and singapore. front pharmacol. 2018;9 doi=10.3389/fphar.2018. walker s, mcauslane n, bujar m, connelly p, liberti l. quality decision-making practices: their application and impact in the development, review and reimbursement of medicines. netherlands: off page, 2017. more back to top © cirs: the centre for innovation in regulatory science 2018 centre for innovation in regulatory science
http://www.cirsci.org/wp-content/uploads/2018/03/liberti_practical_application_regulatory_science.pdf
http://www.cirsci.org/wp-content/uploads/2018/09/cirs-sequence-briefing-rdb68_release2018.pdf
http://www.cirsci.org/wp-content/uploads/2018/02/march-hands-gripping.jpg
http://www.cirsci.org/global-development-track/emarret/
http://www.cirsci.org/pub/
http://www.cirsci.org/global-development-track/flexible-regulatory-pathways/
http://www.cirsci.org/hta-programme/
http://www.cirsci.org/wp-content/uploads/2018/09/cirs-htadock-briefing-rdb69_release2018_11sept2018.pdf
http://www.cirsci.org/global-development-track/gdp-publications-and-presentations/
http://www.cirsci.org/about-us/member-companies/
http://www.cirsci.org/contact-us/
http://www.cirsci.org/stakeholder-survey-early-scientific-advice/
http://www.cirsci.org/factors-influencing-hta-recommendations/
http://www.cirsci.org/wp-content/uploads/2018/05/cirs-rd-briefing-67-04052018_final.pdf
http://www.cirsci.org/decision-making-frameworks/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS
REFERRER http://www.pir.org/
REGISTRAR Public Interest Registry
SERVERS
SERVER org.whois-servers.net
ARGS cirsci.org
PORT 43
TYPE domain
REGISTERED unknown
DOMAIN
NAME cirsci.org
NSERVER
HA2.MARKMONITOR.ZONE 204.13.250.138
HA1.MARKMONITOR.ZONE 208.78.70.138
HA3.MARKMONITOR.ZONE 208.78.71.138
HA4.MARKMONITOR.ZONE 204.13.251.138
The following list shows you to spelling mistakes possible of the internet users for the website searched .